Description

Riminkefon is a kappa opioid receptor agonist[1].—Neuroscience-Neuromodulation–C38H57N7O6—-[1]International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 35, No. 4, 2021–2168572-99-2–707.90—-C[C@H](C1=CC=CC=C1)CNCC(N[C@H](CC2=CC=CC=C2)C(N[C@H](CC(C)C)C(N[C@H](CCCCN)C(N3CCC(CC3)(C(O)=O)N)=O)=O)=O)=O–Neurological Disease–10 mM in DMSO–Opioid Receptor–κ Opioid Receptor/KOR–GPCR/G Protein;Neuronal Signaling–Peptides